Lali Medina Kauwe, has been appointed as co-program leader of the Cancer Biology Program within Cedars-Sinai Cancer at the Samuel Oschin Comprehensive Cancer Institute.Â
Pamela Kunz was named the 2021 Woman Oncologist of the Year by Women Leaders in Oncology.Â
Lynn Wilson has been named deputy chief medical officer for radiation oncology for Smilow Cancer Hospital at Yale New Haven and the Smilow Cancer Hospital Network.Â
Margaret Gilshannon was appointed deputy director for finance and administration at Yale Cancer Center.Â
Christian Linge of SafeBreast Communities from Oslo, Norway, donated $250,000 to the American Cancer Society’s Cancer Crypto Fund.Â
Researchers from Exscientia, the Medical University of Vienna, and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences demonstrated the impact of using Exscientia’s AI-supported precision medicine platform to propose which therapy would be most effective for late-stage hematological cancer patients, based on testing drug responses ex vivo in their own tissue samples.
Participants in a prospective, multi-center, randomized, crossover study (NILE – NCT04908254) reported significantly greater adherence to Dayspring treatment, an active compression treatment for lymphedema, in comparison to the use of pneumatic compression pump.
USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has launched a global registration, phase II clinical trial investigating the efficacy of a potential new breast cancer therapy called ARX788.
Ringling College of Art and Design and Moffitt Cancer Center will present an update on new developments from their collaborative INDEX Virtual Reality project to enhance the cancer patient experience and improve the accuracy of MRI-guided Radiation Therapy.Â
FDA has approved Genentech’s Tecentriq (atezolizumab) as an adjuvant treatment following resection and platinum-based chemotherapy in patients with stage 2 to 3A non-small cell lung cancer whose tumors have PD-L1 expression on ≥ 1% of tumor cells, as determined by an FDA-approved test.Â
